Nosocomial Infections – A Growing Problem

Faecal Incontinence


Contain Clostridium Difficile before it strikes

Flexi-SealTM FMS is a closed system designed to minimize the spread of infection by containing infectious liquid/semi-liquid stool.

It has been scientifically proven in-vitro to contain the spread of C. difficile.1 The closed system may help to reduce environmental contamination from other potentially pathogenic bacteria such as extended-spectrum beta-lactamase (ESBL) producing bacteria and methicillin-resistant Staphylococus aureus (MRSA).

Help reduce complications and cut costs

Nosocomial infections are a common complication of hospitalization and are associated with higher rates of morbidity and mortality.2 These infections lead to extended hospital stays and an increase in treatment and diagnostics that result in increased costs.3,4

  • Infection-related costs can exceed $13,675 per case.5
  • Increases length of stay by 3.6 days per patient.6
  • Up to 20% of hospitalized patients can become infected with C. difficile with a considerable impact on length of stay.6